ReviewInternational journal of molecular sciences2026
Time to Heal: MicroRNA Temporal Dysregulation in Diabetic Foot Ulcers.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Diabetic foot ulcers (DFUs) are a severe complication of diabetes characterized by delayed healing, infection susceptibility, and tissue necrosis. During normal healing, microRNA (miRNA) expression changes over time and helps regulate inflammation, tissue formation, and matrix remodeling. The same miRNA can serve opposing roles depending on cell type, timing, and wound context. Hyperglycemia, hypoxia, and oxidative stress disrupt these processes and prolong inflammation. This review examines how altered miRNA regulation may impair wound-healing transitions and vessel maturation in DFUs. We organize findings from experimental models and human samples into three interpretive patterns: delayed or insufficient induction, aberrant persistence, and temporal inversion or phase-inappropriate expression. Angiogenesis provides an example of how disrupted miRNA timing may impair vascular repair and granulation tissue formation. Circadian regulation may further influence these processes, although direct evidence linking circadian regulation, miRNA dynamics, and human DFUs remains limited. Preclinical studies of miRNA combinations, engineered vesicles, and biomaterial carriers suggest opportunities to coordinate local miRNA delivery with repair needs. The human studies reviewed here do not establish clinical efficacy of a defined miRNA mimic or inhibitor in DFUs. Further translation requires miRNA profiling over time, assessment of the wound's biological stage, and delivery to the relevant cells during the appropriate repair window.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.